PCR30 An Investigation of Patient Journey Assessment in Rare Disease

Autor: Cribbs, K, Kim, D.S., Lahue, BJ

Publikováno v: In Value in Health June 2024 27(6) Supplement:S301-S301

HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

Autor: Blackmore, L, Cribbs, KA, Lahue, BJ

Publikováno v: In Value in Health June 2024 27(6) Supplement:S203-S203

PIN16 CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) IN ACUTE HOSPITALS: A PREVALENT COST ISSUE

Autor: O'Brien, JA, Pitoniak-Morse, C, Lahue, BJ, Davidson, D, Wilson, D, Caro, JJ

Publikováno v: In Value in Health 2006 9(3):A158-A158

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting.

Autor: Eijsink JFH; Isala klinieken and Department of Health Sciences, University of Groningen, Zwolle, The Netherlands., Weiss M; Becton Dickinson and Company, Franklin Lakes, New Jersey, USA., Taneja A; Becton Dickinson and Company, Franklin Lakes, New Jersey, USA ashley.taneja@bd.com.; Fairleigh Dickinson University - Florham Campus, Madison, New Jersey, USA., Edwards T; Becton Dickinson and Company, Franklin Lakes, New Jersey, USA., Girgis H; Becton Dickinson and Company, Le Pont-de-Claix, France., Lahue BJ; Alkemi LLC, Manchester Center, Vermont, USA., Cribbs KA; Alkemi LLC, Manchester Center, Vermont, USA., Postma M; Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Economics, Econometrics & Finance, University of Groningen Faculty of Economics and Business, Groningen, The Netherlands.

Publikováno v: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Oct 25; Vol. 31 (6), pp. 564-570. Date of Electronic Publication: 2024 Oct 25.